Budesonide improves decreased airway conductance in infants with respiratory symptoms

Archives of Disease in Childhood

Volumn 94, Issue 7, 2009, Pages 536-541

  Pelkonen, Anna S ^a   Malmstrom K ^a   Malmberg, L P ^a   Sarna, S ^b   Turpeinen, M ^a   Kajosaari, M ^c   Haahtela, T ^a   Makela M J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; PLACEBO; PREDNISOLONE; SALBUTAMOL; TERBUTALINE;

AIRWAY CONDUCTANCE; ARTICLE; BODY PLETHYSMOGRAPHY; BRONCHOSCOPY; BRONCHUS OBSTRUCTION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DYSPNEA; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INFANT; LUNG FUNCTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE DRUG DOSE; TREATMENT RESPONSE; WHEEZING;

ADMINISTRATION, ORAL; AIRWAY RESISTANCE; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD, PRESCHOOL; COUGH; DYSPNEA; FEMALE; FINLAND; GLUCOCORTICOIDS; HUMANS; INFANT; LUNG; MALE; RESPIRATORY SOUNDS; TERBUTALINE; TREATMENT OUTCOME;

EID: 67649690493     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.132100     Document Type: Article

References (34)

1. National Asthma Educational and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma - update on selected topics 2002. J Allergy Clin Immunol 2002;110(Suppl):S141-S219.
2. Dahl R, Bjermer L. Nordic consensus report on asthma management. Respir Med 2000;94:299-327. (Pubitemid 30323566)
3. Warner JO, Naspitz CK. Third international paediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998;25:1-17. (Pubitemid 28079927)
4. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992;146:547-554
5. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071-1076 (Pubitemid 36369558)
6. Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacoline responsiveness in 2- to 5-year-old asthmatic children. Am J Respir Crit Care Med 2000;162:1500-1506 (Pubitemid 30826178)
7. Pao CS, McKenzie SA. Randomized controlled trial of fluticasone in preschool children with intermittent wheeze. Am J Respir Crit Care Med 2002;166:945-949 (Pubitemid 35193223)
8. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-1996
9. Mellon M. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group. J Allergy Clin Immunol 1999;104:S191-9.
10. Calpin C, Macarthur C, Stephens D, et al. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systematic review of the literature. J Allergy Clin Immunol 1997;100:452-457 (Pubitemid 27441299)
11. Bisgaard H, Gillies J, Groenewald M, et al. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children. Am J Respir Crit Care Med 1999;160:126-131
12. Bisgaard H, Allen D, Milanowski J, et al. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004;113:e87-e94.
13. Teper AM, Kofman CD, Szulman GA, et al. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med 2005;171:587-590 (Pubitemid 40365413)
14. Teper AM, Colom AJ, Kofman CD, et al. Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatr Pulmonol 2004;37:111-115 (Pubitemid 38120980)
15. Roorda RJ, Mezei G, Bisgaard H, et al. Response of preschool children with asthma symptoms to fluticasone propionate. J Allergy Clin Immunol 2001;108:540-546 (Pubitemid 32978024)
16. Baker JW, Mellon M, Wald J, et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics 1999;103:414-421 (Pubitemid 29274535)
17. Chavasse RJ, Bastian-Lee Y, Richter H, et al. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone. Arch Dis Child 2001;85:143-148 (Pubitemid 32701682)
18. Devupalli CS, Haaland G, Pettersen M, et al. Effect of inhaled steroids on lung function in young children: a cohort study. Eur Respir J 2004;23:869-875 (Pubitemid 38807361)
19. Moeller A, Franklin P, Hall GL, et al. Inhaled fluticasone dipropionate decreased levels of nitric oxide in recurrent wheezy infants. Pediatr Pulmonol 2004;38:250-255 (Pubitemid 39095685)
20. Hofhuis W, van der Wiel EC, Nieuwhof EM, et al. Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants. Am J Respir Crit Care Med 2005;171:328-333 (Pubitemid 40223399)
21. Stick SM, Burton PR, Clough JB, et al. The effect of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants. Arch Dis Child 1995;73:327-332
22. Castro-Rodriguez JA, Holberg CJ, Wright AL, et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-1406 (Pubitemid 30826162)
23. Malmberg LP, Pelkonen A, Hakulinen A, et al. Intraindividual variability of infant whole-body plethysmographic measurements: effects of age and disease. Pediatr Pulmonol 1999;28:356-362 (Pubitemid 29523448)
24. Kraemer R, Graf Bigler U, Casaulta Aebischer C, et al. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration 1997;64:342-349 (Pubitemid 27365661)
25. Lowe LA, Simpson A, Woodcock A, et al. Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med 2005;171:231-237
26. Vonk JM, Boezen HM. Predicting adult asthma in childhood. Curr Opin Pulm Med 2006;12:42-47 (Pubitemid 44378577)
27. Saglani S, Malmström K, Pelkonen AS, et al. Airway remodelling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-727 (Pubitemid 40471142)
28. Horvarth G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J 2006;27:172-187 (Pubitemid 43092682)
29. Wildhaber JH, Dore ND, Devadason SG, et al. Comparison of subjective and objective measures in recurrently wheezy infants. Respiration 2002;69:397-405.
30. Martinez FD, Wright AL, Taussig LM, et al. The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138
31. Turpeinen M, Nikander K, Malmberg LP, et al. Metered dose inhaler add-on devices: is the inhaled mass of drug dependent on the size of the infants. J Aerosol Med 1999;12:171-176 (Pubitemid 29441627)
32. Macklem PT. The physiology of small airways. Am J Respir Crit Care Med 1998;157:S181-S183. (Pubitemid 28232580)
33. Childhood Asthma Management Program (CAMP) Research Group. Longterm effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-1063 (Pubitemid 30761076)
34. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006;354:1998-2005.